IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 317 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $949,000 | -94.5% | 28,200 | -92.3% | 0.00% | -88.2% |
| Q1 2020 | $17,320,000 | +41.2% | 366,320 | +60.7% | 0.02% | -15.0% |
| Q4 2019 | $12,270,000 | -66.7% | 228,001 | -66.0% | 0.02% | -67.2% |
| Q3 2019 | $36,801,000 | +236.8% | 669,687 | +245.9% | 0.06% | +221.1% |
| Q2 2019 | $10,926,000 | +243.8% | 193,600 | +209.9% | 0.02% | +216.7% |
| Q2 2017 | $3,178,000 | +26.6% | 62,464 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $2,511,000 | -11.4% | 62,464 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $2,833,000 | +3.3% | 62,464 | -16.6% | 0.01% | 0.0% |
| Q3 2016 | $2,743,000 | -18.0% | 74,864 | -47.9% | 0.01% | -16.7% |
| Q2 2016 | $3,344,000 | +10.3% | 143,564 | +91.8% | 0.01% | 0.0% |
| Q1 2016 | $3,032,000 | -99.9% | 74,864 | +88.0% | 0.01% | 0.0% |
| Q4 2015 | $2,465,495,000 | – | 39,811 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |